Roche, Cobalt Drop Claims Over One Boniva Patent
Hoffmann-La Roche Inc. and Canadian generic-drug maker Cobalt Pharmaceuticals Inc. have agreed to dismiss claims against one another regarding one patent for the osteoporosis drug Boniva. But Friday's dismissal made no...To view the full article, register now.
Already a subscriber? Click here to view full article